UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000027018
Receipt No. R000030979
Official scientific title of the study Intravenous paracetamol for closure of the ductus arteriosus after premature birth
Date of disclosure of the study information 2017/04/17
Last modified on 2018/06/21 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Intravenous paracetamol for closure of the ductus arteriosus after premature birth
Title of the study (Brief title) Intravenous paracetamol for closure of the ductus arteriosus after premature birth
Region
Japan

Condition
Condition PDA
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate of safety and efficacy of paracetamol for PDA
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Pharmacologic closure of PDA
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design expanded access
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Administration of paracetamol (dose of 15mg/kg every 6h for 3days)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Vely low birth weight infants who born from 23 to 31 weeks of gestational age and had failed and had contraindications to indomethacin therapy.
Key exclusion criteria Infants who born less than 23weeks of gestational age or some or has some syndrome.
Target sample size 6

Research contact person
Name of lead principal investigator Matsumura Shun
Organization Saitama Medical Center, Saitama Medical University
Division name Pediatrics
Address Kamoda 1984, Kawagoe, Saitama, Japan
TEL 049-228-3400
Email mshun1203@yahoo.co.jp

Public contact
Name of contact person Matsumura Shun
Organization Saitama Medical Center, Saitama Medical University
Division name Pediatrics
Address Kamoda 1984, Kawagoe, Saitama, Japan
TEL 049-228-3400
Homepage URL
Email mshun1203@yahoo.co.jp

Sponsor
Institute Saitama Medical Center, Saitama Medical University
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 17 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 04 Month 06 Day
Anticipated trial start date
2017 Year 06 Month 01 Day
Last follow-up date
2018 Year 03 Month 31 Day
Date of closure to data entry
2019 Year 03 Month 31 Day
Date trial data considered complete
2019 Year 03 Month 31 Day
Date analysis concluded
2019 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 04 Month 17 Day
Last modified on
2018 Year 06 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030979